1. Advances in bioengineering. (2020) Other Names: Vyas, Renu Record Type: Book Extent: 1 online resource (229 p.) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Building and analysis of protein-protein interactions related to diabetes mellitus using support vector machine, biomedical text mining and network analysis. (December 2016) Authors: Vyas, Renu; Bapat, Sanket; Jain, Esha; Karthikeyan, Muthukumarasamy; Tambe, Sanjeev; Kulkarni, Bhaskar D. Journal: Computational biology and chemistry Issue: Volume 65(2016) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Computational analysis of next generation sequencing data and its applications in clinical oncology. (2018) Authors: Wadapurkar, Rucha M.; Vyas, Renu Journal: Informatics in medicine unlocked Issue: Volume 11(2018) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Computational studies reveal co-occurrence of two mutations in IL7R gene of high-grade serous carcinoma patients. Issue 23 (19th December 2022) Authors: Wadapurkar, Rucha M.; Sivaram, Aruna; Vyas, Renu Journal: Journal of biomolecular structure & dynamics Issue: Volume 40:Issue 23(2022) Page Start: 13310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identification of potent chromone embedded [1, 2, 3]-triazoles as novel anti-tubercular agents. Issue 4 (4th April 2018) Authors: Nalla, Viswanadh; Shaikh, Aslam; Bapat, Sanket; Vyas, Renu; Karthikeyan, M.; Yogeeswari, P.; Sriram, D.; Muthukrishnan, M. Journal: Royal Society open science Issue: Volume 5:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Microchemical enantioseparation of betaxolol and orciprenaline by reversed phase HPLC. Issue 10 (20th August 2020) Authors: Nagar, Hariom; Vyas, Renu; Bhushan, Ravi Journal: Separation science plus Issue: Volume 3:Issue 10(2020) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. Issue 18 (12th December 2021) Authors: Lokhande, Kiran Bharat; Doiphode, Sayali; Vyas, Renu; Swamy, K. Venkateswara Journal: Journal of biomolecular structure & dynamics Issue: Volume 39:Issue 18(2021) Page Start: 7294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reversed‐phase‐HPLC enantioseparation and control of enantiomeric purity of duloxetine using a new chiral reagent and recovery of enantiomers. (8th September 2021) Authors: Vyas, Renu; Bhushan, Ravi; Nagar, Hariom; Sharma, Aishwarya Journal: Biomedical chromatography Issue: Volume 35:Number 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. RNA-Seq Analysis of Clinical Samples from TCGA Reveal Molecular Signatures for Ovarian Cancer. (21st April 2023) Authors: Wadapurkar, Rucha M.; Sivaram, Aruna; Vyas, Renu Journal: Cancer investigation Issue: Volume 41:Number 4(2023) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Spirochromone-chalcone conjugates as antitubercular agents: synthesis, bio evaluation and molecular modeling studies. Issue 129 (15th December 2015) Authors: Mujahid, M.; Yogeeswari, P.; Sriram, D.; Basavanag, U. M. V.; Díaz-Cervantes, Erik; Córdoba-Bahena, Luis; Robles, Juvencio; Gonnade, R. G.; Karthikeyan, M.; Vyas, Renu; Muthukrishnan, M. Journal: RSC advances Issue: Volume 5:Issue 129(2015) Page Start: 106448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗